Quarry LP’s Beam Therapeutics BEAM Stock Holding History

Quarry LP’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$172K	Sell	5,000 -2,000	-29%	-$60.4K	0.01%	339
2026 Q1	$167K	Buy	7,000 +2,000	+40%	+$55.5K	0.03%	368
2025 Q4	$139K	Sell	5,000 -4,849	-49%	-$124K	0.02%	341
2025 Q3	$239K	Buy	9,849 +1,849	+23%	+$36.8K	0.05%	303
2025 Q2	$136K	Buy	8,000 +3,500	+78%	+$61K	0.03%	446
2025 Q1	$87.9K	Buy	4,500 +3,000	+200%	+$78.6K	0.02%	569
2024 Q4	$37.2K	Sell	1,500 -4,500	-75%	-$115K	0.01%	909
2024 Q3	$147K	Buy	6,000 +2,400	+67%	+$62K	0.04%	311
2024 Q2	$84.3K	Buy	3,600 +2,800	+350%	+$68.8K	0.02%	416
2024 Q1	$26.4K	Buy	+800	New	+$24.9K	0.01%	787

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Quarry LP's BEAM Position: Q2 2026 in Review

Quarry LP reduced its Beam Therapeutics (BEAM) stake by 29% in Q2 2026, selling an estimated $60.4K and leaving 5,000 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #339.

Quarry LP first reported a position in BEAM in Q1 2024 and has held it in 10 quarters since. The position peaked at $239K in Q3 2025. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Quarry LP held 5,000 shares of Beam Therapeutics worth $172K as of Q2 2026.
Quarry LP sold 2,000 Beam Therapeutics shares in Q2 2026, an estimated $60.4K.
Beam Therapeutics made up 0.01% of Quarry LP's portfolio in Q2 2026, its #339 holding.
Quarry LP first reported a position in Beam Therapeutics in Q1 2024 and has held it in 10 quarters since.
Quarry LP's Beam Therapeutics position peaked at $239K in Q3 2025.
278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.